IHS Chemical Week

Regions :: Southeast Asia

Roche Agrees to Buy Lonza's Singapore Manufacturing Facility

1:33 AM MDT | August 31, 2009 | Natasha Alperowicz

Lonza has announced that Genentech Singapore, a wholly-owned member of the Roche Group, has elected to exercise an option to purchase from Lonza its cell culture biologic manufacturing facility in Singapore for $290 million plus additional milestone payments of $70 million. The facility, which is mechanically completed, will be merged with Genentech Singapore's existing biologic manufacturing facility. As part of the integration between Roche's and Genentech's combined technical operations, the biotechnology production facilities in Singapore currently operating...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa